CO4900050A1 - Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba - Google Patents
Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gabaInfo
- Publication number
- CO4900050A1 CO4900050A1 CO97040267A CO97040267A CO4900050A1 CO 4900050 A1 CO4900050 A1 CO 4900050A1 CO 97040267 A CO97040267 A CO 97040267A CO 97040267 A CO97040267 A CO 97040267A CO 4900050 A1 CO4900050 A1 CO 4900050A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- low
- hydrogen
- weight alkyl
- weight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Multicomponent Fibers (AREA)
Abstract
Un compuesto de la fórmula: o sus sales no tóxicas farmacéuticamente aceptables en donde: T es halógeno, hidrógeno, hidroxi, nitro, amino o alcoxi de bajo peso; X es hidrógeno, hidroxilo o alquilo de bajo peso; W es fenilo o fenilaquilo en donde cada alquilo está opcionalmente sustituido con hasta 5 grupos independientemente seleccionados a partir de halógeno, hidroxi,alquilo de bajo peso, cicloalquilo que tiene de 3-7 átomos de carbono, amino, mono o dialquilamino en donde cada alquilo es independientemente alquilo de bajo peso o cicloalquilo que tiene de 3-7 átomos de carbono, alcoxi de bajo peso, cicloalquil alcoxi que tiene de 3-7 átomos de carbono, alquilendioxi, o NR1 COR2 , COR2 , o CONR1 R2 en donde R1 y R2 son iguales o diferentes y representan hidrógeno, alquilo de bajo peso o cicloalquilo que tiene de 3-7 átomos de carbono; y representa en donde: - 2 -Y representa nitrógeno o C-R4 ; representa N-R7 o un átomo de carbono sustituido con R8 y R9 , n es 1, 2, 3 ó 4; R3 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilaquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; R4 es halógeno o trifluormetilo; o -OR10 , -COR10 , -CO2 R10 , -OCOR10 , o -R10 en donde R10 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilaquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o -CONR11 R12 o (CH2 )m NR11 R12 , en donde m es 0, 1, ó 2; R11 representa hidrógeno, alquilo de bajo peso, y R12 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o NR11 R12 forma un grupo heterocíclico el cual es morfolinilo, piperidinilo, pirrolidinilo, o N-alquil piperazinilo; R5 y R6 son iguales o diferentes y representan hidrógeno, halógeno, alquilo de bajo peso, o alcoxi de bajo peso; R7 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; R8 es hidrógeno o alquilo de bajo peso; y R9 es COR13 , CO2 R13 o -R13 , en donde R13 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o R9 es CONR14 R15 o -(CH2 )k NR14 R15 , en donde k es 0, 1, ó 2; R14 representa hidrógeno, alquilo de bajo peso, y R15 es hidrógeno, fenilo, 2-, 3-, o 4-piridilo, alquilo de bajo peso, o fenilalquilo o 2-, 3-, o 4-piridilalquilo en donde cada alquilo es alquilo de bajo peso; o NR14 R15 forma un grupo heterocíclico el cual es morfolilo, piperidilo, pirrolidilo, o N-alquil piperazilo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/683,066 US5750702A (en) | 1993-10-27 | 1996-07-16 | Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
| PCT/US1997/004623 WO1997034870A1 (en) | 1996-03-22 | 1997-03-20 | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4900050A1 true CO4900050A1 (es) | 2000-03-27 |
Family
ID=24742434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97040267A CO4900050A1 (es) | 1996-07-16 | 1997-07-16 | Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5750702A (es) |
| AU (2) | AU2832897A (es) |
| CO (1) | CO4900050A1 (es) |
| DZ (1) | DZ2271A1 (es) |
| HR (1) | HRP970385A2 (es) |
| MA (1) | MA27120A1 (es) |
| PA (1) | PA8434101A1 (es) |
| PE (1) | PE91798A1 (es) |
| WO (2) | WO1998002433A1 (es) |
| ZA (1) | ZA976244B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034870A1 (en) | 1996-03-22 | 1997-09-25 | Neurogen Corporation | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
| CZ20001769A3 (cs) | 1997-11-13 | 2001-09-12 | Pfizer Products Inc. | Způsob výroby pyrrolkarboxamidů |
| PT1048651E (pt) * | 1997-12-03 | 2003-09-30 | Taisho Pharmaceutical Co Ltd | Compostos tetraciclicos contendo azoto |
| EP1056724B1 (en) | 1998-02-26 | 2005-05-25 | Neurogen Corporation | Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| AU2879799A (en) * | 1998-02-26 | 1999-09-15 | Neurogen Corporation | 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands |
| JPH11279040A (ja) | 1998-03-27 | 1999-10-12 | Kao Corp | 皮膚外用剤 |
| GB9812038D0 (en) | 1998-06-04 | 1998-07-29 | Merck Sharp & Dohme | Therapeutic compound |
| EP1177177B1 (en) * | 1999-05-06 | 2005-02-23 | Neurogen Corporation | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| US6375948B1 (en) | 1999-07-12 | 2002-04-23 | Kao Corporation | Treating method for suppressing hair growth |
| US20050014939A1 (en) * | 1999-08-31 | 2005-01-20 | Neurogen Corporation | Fused pyrrolecarboxamides: GABA brain receptor ligands |
| US7109351B1 (en) * | 1999-08-31 | 2006-09-19 | Neurogen Corporation | Fused pyrrolecarboxamides; GABA brain receptor ligands |
| AU2001264932A1 (en) | 2000-05-26 | 2001-12-11 | Neurogen Corporation | Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands |
| AU2001277731A1 (en) * | 2000-08-09 | 2002-02-18 | Welfide Corporation | Fused bicyclic amide compounds and medicinal use thereof |
| WO2002046155A1 (en) * | 2000-12-04 | 2002-06-13 | Pfizer Products Inc. | Synthesis of fused pyrrolecarboxamides |
| US6861529B2 (en) * | 2001-07-06 | 2005-03-01 | Pfizer Inc | Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives |
| US20060100196A1 (en) * | 2001-09-24 | 2006-05-11 | Andrea Gailunas | Substituted amines for the treatment of alzheimer's disease |
| BR0214301A (pt) * | 2001-11-19 | 2004-10-13 | Neurogen Corp | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para tratar doenças ou condições, para potencializar um efeito terapêutico de um agente do snc, para melhorar a memória recente de um paciente, para determinar a presença ou ausência de um receptor de gabaa em uma amostra, e para alterar a atividade de transdução de sinal de receptor de gabaa, preparação farmacêutica acondicionada, e, uso de um composto ou sal |
| US6673811B1 (en) * | 2001-11-19 | 2004-01-06 | Neurogen Corporation | 1H-pyrrolo [3,2-b] pyridine-3-carboxylic acid amines as GABAA receptor ligands |
| EP1472252A1 (en) * | 2002-02-07 | 2004-11-03 | Neurogen Corporation | Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| US20040122218A1 (en) * | 2002-12-20 | 2004-06-24 | Sean Turner | Pyrrolopyridine potassium channel openers |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
| JP2009513672A (ja) * | 2005-10-31 | 2009-04-02 | ブレインセルス,インコーポレイティド | 神経発生のgaba受容体媒介調節 |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
| US10954231B2 (en) | 2006-10-16 | 2021-03-23 | Bionomics Limited | Anxiolytic compounds |
| AU2007312936B2 (en) | 2006-10-16 | 2013-09-26 | Bionomics Limited | Novel anxiolytic compounds |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| AU2012222874B2 (en) | 2011-03-02 | 2015-04-16 | Bionomics Limited | Novel small-molecules as therapeutics |
| WO2012151640A1 (en) | 2011-05-12 | 2012-11-15 | Bionomics Limited | Methods for preparing naphthyridines |
| US12157753B2 (en) * | 2019-01-17 | 2024-12-03 | ViiV Healthcare UK (No.4) Limited | Process for preparing Fostemsavir |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455943A (en) * | 1966-10-21 | 1969-07-15 | American Cyanamid Co | Certain 5,8-dihydro-beta-carbolines |
| JPS57123180A (en) * | 1980-12-17 | 1982-07-31 | Schering Ag | 3-substituted beta-carboline, manufacture and psychotropic drug containing same |
| DE3335323A1 (de) * | 1983-09-27 | 1985-04-04 | Schering AG, 1000 Berlin und 4709 Bergkamen | Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE3535927A1 (de) * | 1985-10-04 | 1987-04-09 | Schering Ag | 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
| AU652968B2 (en) * | 1990-10-09 | 1994-09-15 | Neurogen Corporation | Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| US5243049A (en) * | 1992-01-22 | 1993-09-07 | Neurogen Corporation | Certain pyrroloquinolinones: a new class of GABA brain receptor ligands |
| US5266698A (en) * | 1992-04-30 | 1993-11-30 | Neurogen Corporation | Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands |
| US5484944A (en) * | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
| US5804686A (en) * | 1996-01-19 | 1998-09-08 | Neurogen Corporation | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
-
1996
- 1996-07-16 US US08/683,066 patent/US5750702A/en not_active Expired - Fee Related
-
1997
- 1997-05-09 AU AU28328/97A patent/AU2832897A/en not_active Abandoned
- 1997-05-09 WO PCT/US1997/007830 patent/WO1998002433A1/en not_active Ceased
- 1997-07-14 WO PCT/US1997/012153 patent/WO1998002420A1/en not_active Ceased
- 1997-07-14 AU AU36604/97A patent/AU3660497A/en not_active Abandoned
- 1997-07-15 ZA ZA976244A patent/ZA976244B/xx unknown
- 1997-07-16 HR HR08/683,066A patent/HRP970385A2/hr not_active Application Discontinuation
- 1997-07-16 PA PA19978434101A patent/PA8434101A1/es unknown
- 1997-07-16 DZ DZ970121A patent/DZ2271A1/fr active
- 1997-07-16 PE PE1997000632A patent/PE91798A1/es not_active Application Discontinuation
- 1997-07-16 MA MA24720A patent/MA27120A1/fr unknown
- 1997-07-16 CO CO97040267A patent/CO4900050A1/es unknown
-
1998
- 1998-05-05 US US09/073,030 patent/US5925770A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2832897A (en) | 1998-02-09 |
| HRP970385A2 (en) | 1998-08-31 |
| WO1998002420A1 (en) | 1998-01-22 |
| PA8434101A1 (es) | 2000-05-24 |
| US5925770A (en) | 1999-07-20 |
| ZA976244B (en) | 1999-01-21 |
| US5750702A (en) | 1998-05-12 |
| PE91798A1 (es) | 1999-01-07 |
| AU3660497A (en) | 1998-02-09 |
| WO1998002433A1 (en) | 1998-01-22 |
| DZ2271A1 (fr) | 2002-12-18 |
| MA27120A1 (fr) | 2005-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4900050A1 (es) | Pirrolcarboxanilidas fusionadas; una nueva clase de ligan- dos receptores cerebrales de gaba | |
| FI961776A0 (fi) | Tiettyjä fuusioituneita pyrrolikarboksianilideja; uusi aivojen GABA-reseptoriligandien luokka | |
| CO5630036A2 (es) | Nuevos derivados indol con afinidad por el receptor 5-ht6 | |
| CY1110399T1 (el) | Ρυθμιστες της τετραϋδροπυρανυλο κυκλοπεντυλο τετραϋδροπυριδοπυριδινης για την ενεργοτητα των υποδοχεων των χημειοκινων | |
| FI911096A0 (fi) | N-(4-piperidyl) dihydrobenzofuran)karboxamid- eller n-(4-piperidyl)(dihydro-2h- benzopyran) karboxamidderivat. | |
| ES2193839B1 (es) | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. | |
| CY1107677T1 (el) | Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine | |
| CY1108352T1 (el) | Υποκατασταθεισες 1,4-βενζοδιαζεπινες και χρησεις τους για την αγωγη του καρκινου | |
| CO4650042A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| CO5601018A2 (es) | Derivados de n-fenil-2-pirimidin-amina | |
| AR035548A1 (es) | Compuestos organicos | |
| ECSP045369A (es) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
| CY1106858T1 (el) | Νεα παραγωγα κυκλικου αμιδιου | |
| ATE383338T1 (de) | N-(phenyl(piperidin-2-yl)methyl)benzamid-deriva e,verfahren zu deren herstellung und ihre therapeutische verwendung | |
| BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
| MX9806246A (es) | PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-. | |
| HUP0001165A2 (hu) | NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra | |
| EA200101230A1 (ru) | Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции | |
| TW200510309A (en) | Chemical compounds | |
| DK0888356T3 (da) | Kondenserede 2,3-benzodiazepinderivater og deres anvendelse som AMPA-receptohaemmere | |
| CO5180541A1 (es) | Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros | |
| DE60000978D1 (de) | 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose | |
| NZ335975A (en) | Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases | |
| CO4900049A1 (es) | Ciertas pirrolacarboxamidas fusionadas; una nueva clase de ligandos receptores cerebrales de gaba | |
| DK1716097T3 (da) | Ny fremgangsmåde til syntese af en-amidderivater |